Direct ovarian effects and safety aspects of GnRH agonists and antagonists

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.5, Iss.3, 2002-11, pp. : 8-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of GnRH agonists and antagonists

By Tarlatzis Basil C Bili Helen

Expert Opinion on Drug Safety, Vol. 3, Iss. 1, 2004-01 ,pp. : 39-46

Informa Healthcare

Access to resources Recommend Favorite

Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS

By Vrtačnik-Bokal Eda Virant Klun Irma Verdenik Ivan

Reproductive BioMedicine Online, Vol. 18, Iss. 1, 2009-01 ,pp. : 21-28

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

GnRH agonists and antagonists in assisted reproduction: pregnancy rate

By Engel JB Griesinger G Schultze-Mosgau A Felberbaum R Diedrich K

Reproductive BioMedicine Online, Vol. 13, Iss. 1, 2006-07 ,pp. : 84-87

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

GnRH antagonists in IVF

By Kolibianakis Efstratios M Tarlatzis Basil Devroey Paul

Reproductive BioMedicine Online, Vol. 10, Iss. 6, 2005-06 ,pp. : 705-712

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

GnRH agonists: US FDA reviews CV safety

Reactions Weekly, Vol. 1, Iss. 1300, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite